An Experimental Study on Utilization of Iron Ore Tailings (IOT) and Waste Glass Powder in Concrete

Cement manufacturing industry is one of the carbon dioxide emitting sources besides deforestation burning of fossil fuels. The global warming is caused by the emission of green house gases, such as CO2, to the atmosphere. Among the greenhouse gases, CO2 contributes about 65% of global warming. The global cement industry contributes about 7% of green house gas emission to the earth’s atmosphere. In order to address environmental effects associated with cement manufacturing, there is a need to develop alternative binders to make concrete. Consequently extensive research is on going into the use of cement replacements, using many waste materials industrial by products. Efforts have been made in the concrete industry to use waste glass as partial replacement of cement and also in recent years almost every mineral producing country is facing the problem of better utilization of mine waste because of its accumulation lack of suitable storage space. In this study, finely powdered waste glass from industries and Iron Ore Tailings (IOT) produced from mining areas are used as a partial replacement  of cement and fine aggregates in concrete respectively.  This work examines the possibility of using Glass powder and iron ore tailing as a partial replacement of cement and fine aggregate in concrete. In the present study  Glass powder and Iron Ore Tailing  ( IOT )  are partially replaced by 10%, 20%, 30% and  40%  tested for its compressive, flexural strength for 7, 28 and 56 days of curing and were compared with those of conventional concrete. Keywords: Glass Powder – GP, Iron Ore Tailings – IOT, Conventional Concrete - C

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)

The Asian Pacific Association for the Study of the Liver (APASL) set up a working party on acute-on-chronic liver failure (ACLF) in 2004, with a mandate to develop consensus guidelines on various aspects of ACLF relevant to disease patterns and clinical practice in the Asia-Pacific region. Experts predominantly from the Asia–Pacific region constituted this working party and were requested to identify different issues of ACLF and develop the consensus guidelines. A 2-day meeting of the working party was held on January 22–23, 2008, at New Delhi, India, to discuss and finalize the consensus statements. Only those statements that were unanimously approved by the experts were accepted. These statements were circulated to all the experts and subsequently presented at the Annual Conference of the APASL at Seoul, Korea, in March 2008. The consensus statements along with relevant background information are presented in this review

Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort (Nature, (2020), 583, 7814, (90-95), 10.1038/s41586-020-2265-1)

An amendment to this paper has been published and can be accessed via a link at the top of the paper